Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 10, 2002
Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapiesDarren J Kelly, Petri Aaltonen, Alison J Cox, et al.
Plos One|October 17, 2012
A purpose-synthesised anti-fibrotic agent attenuates experimental kidney diseases in the ratRichard E Gilbert, Yuan Zhang, Spencer J Williams, et al.
Trials|September 11, 2016
Design and protocol for the Dialysis Optimal Health Program (DOHP) randomised controlled trialSimon R Knowles, Chantal F Ski, Robyn Langham, et al.
Investigative Ophthalmology & Visual Science|April 19, 2011
Identification of urinary biomarkers for age-related macular degenerationRobyn H Guymer, Lingwei W Tao, Jonathan K Goh, et al.
Journal of the American Society of Nephrology : JASN|March 24, 2012
Effects of biocompatible versus standard fluid on peritoneal dialysis outcomesDavid W Johnson, Fiona G Brown, Margaret Clarke, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 20, 2012
The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: the balANZ trialDavid W Johnson, Fiona G Brown, Margaret Clarke, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 4, 2012
The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trialDavid W Johnson, Fiona G Brown, Margaret Clarke, et al.
Rural and Remote Health|September 29, 2021
Rationale and protocol for the Nursing and Allied Health Graduate Outcomes Tracking (NAHGOT) study: a large-scale longitudinal investigation of graduate practice destinationsKeith Paul Sutton, Alison Beauchamp, Tony Smith, et al.
Frontiers in Medicine|February 26, 2025
Requirements and special considerations for drug trials with children across six jurisdictions: 2. Ethics review in the regulatory approval processBreanne Stewart, Pirkko Lepola, Gunter F Egger, et al.
Frontiers in Medicine|April 30, 2025
Requirements and special considerations for drug trials with children across six jurisdictions: 1. Clinical trial application review in the regulatory approval processBreanne Stewart, Pirkko Lepola, Gunter F Egger, et al.
Pageof 2